BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1395924)

  • 1. [The expression of C-myc oncogene in leukemia and its relationship to clinical symptoms].
    Yang PM; Fu L
    Zhonghua Nei Ke Za Zhi; 1992 Mar; 31(3):143-5, 187. PubMed ID: 1395924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the c-myc and N-ras genes in acute myelogenous leukemia cells which manifest the constitutive expression of the c-myc gene.
    Kadam P; Steele P; Li YQ; Preisler H
    Anticancer Res; 1993; 13(3):747-51. PubMed ID: 8317907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of IFN-alpha and IFN-alpha combined with GM-CSF on expression of the genes related to cell apoptosis of MNCs from bone marrow in CML patients].
    Tang LJ; Chen HC; Peng XH
    Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):570-2. PubMed ID: 12516408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC in chronic myeloid leukemia: induction of aberrant DNA synthesis and association with poor response to imatinib.
    Albajar M; Gómez-Casares MT; Llorca J; Mauleon I; Vaqué JP; Acosta JC; Bermúdez A; Donato N; Delgado MD; León J
    Mol Cancer Res; 2011 May; 9(5):564-76. PubMed ID: 21460180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
    Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of Bcl-2 protein and the amplification of c-myc gene in patients with chronic myeloid leukemia].
    Strnad M; Brajusković G; Strelić N; Zivanović BT; Tukić L; Stamatović D
    Vojnosanit Pregl; 2006 Apr; 63(4):364-9. PubMed ID: 16683403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of c-Myc protooncogene in chronic myelogenous leukemia.
    Nieborowska-Skórska M; Ratajczak MZ; Calabretta B; Skórski T
    Folia Histochem Cytobiol; 1994; 32(4):231-4. PubMed ID: 7758616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation status of c-myc oncogene in leukemic cells: hypomethylation in acute leukemia derived from myelodysplastic syndromes.
    Tsukamoto N; Morita K; Karasawa M; Omine M
    Exp Hematol; 1992 Oct; 20(9):1061-4. PubMed ID: 1468540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal regulation of the myc gene in myeloid leukemia.
    Gopal V; Kadam P; Preisler H; Hulette B; Li YQ; Steele P; Freeman J; Banavali S
    Med Oncol Tumor Pharmacother; 1992; 9(3):139-47. PubMed ID: 1341325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of c-fes gene in leukemia cells and its clinical significance].
    Zhang YL; Ren JH; Guo XN; Zhang JN; Wang Y; Qiao SK; Lin FR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1429-33. PubMed ID: 20030920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
    Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amplification and rearrangement of proto-oncogene c-abl in human leukemia cells].
    Jin XM; Miao J; Xu Y; Deng GR
    Zhonghua Zhong Liu Za Zhi; 1988 May; 10(3):167-70. PubMed ID: 3219975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias: relationship to the expression of cell cycle-related genes.
    Ferrari S; Tagliafico E; Ceccherelli G; Selleri L; Calabretta B; Donelli A; Temperani P; Sarti M; Sacchi S; Emilia G
    Leukemia; 1989 Jun; 3(6):423-30. PubMed ID: 2542700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis.
    Soupir CP; Vergilio JA; Dal Cin P; Muzikansky A; Kantarjian H; Jones D; Hasserjian RP
    Am J Clin Pathol; 2007 Apr; 127(4):642-50. PubMed ID: 17369142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
    Cuenco GM; Ren R
    Oncogene; 2001 Dec; 20(57):8236-48. PubMed ID: 11781838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.
    Sakhinia E; Faranghpour M; Liu Yin JA; Brady G; Hoyland JA; Byers RJ
    Br J Haematol; 2005 Jul; 130(2):233-48. PubMed ID: 16029452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of c-myc expression in individual leukemic cells.
    Preisler HD; Sato H; Yang PM; Wilson M; Kaufman C; Watt R
    Leuk Res; 1988; 12(6):507-16. PubMed ID: 3165487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-myc expression in cell lines derived from chronic myeloid leukemia.
    Gómez-Casares MT; Vaqué JP; Lemes A; Molero T; Delgado MD; León J
    Haematologica; 2004 Feb; 89(2):241-3. PubMed ID: 15003904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.